Dr. Corrado Lodigiani has been assistant at the Thrombosis Centre of Humanitas research Hospital from 1998 to 2013 and he became Unit Director in 2013.
Humanitas Thrombosis Center is a state-of-the-art service for the proper management of the diagnosis and therapy of venous thromboembolic pathology (deep and superficial venous thrombosis, pulmonary thromboembolism, visceral venous thrombosis) and arterial (myocardial infarction, cerebral stroke, peripheral arterial disease).
Other also rare diseases treated are atypical thrombosis, such as the vascular circulation of the retina, the hearing system and the placental circulation during pregnancy.
Dr. Lodigiani adopts the multidisciplinary approach and works in collaboration with all medical and surgical specialties. In particular, he carries out clinical and instrumental diagnostics (vascular ecocolordoppler) and research on the causes, diagnosis and therapy of thrombotic and bleeding disorders, congenital and acquired. His clinical activity also involves the diagnosis and management of patients suffering from bleeding diseases, such as haemophilia, von Willebrand’s disease and platelet diseases.
In recent years, he has devoted himself with particular interest to the testing, in the role of Principal Investigator in International Clinical Studies, of new antithrombotic drugs and, above all, anticoagulants, which are about to be marketed and will constitute a valid and safe alternative to traditional oral anticoagulant therapy (DOACs). He is also working, with great interest, on researching the causes of idiopathic infertility and the usefulness and effectiveness of some therapeutic strategies, such as the use of anticoagulant drugs, improving the results of artificial insemination procedures. He is the author of numerous articles in international scientific journals and speaker at numerous national and international conferences.
Mostrar másDr. Corrado Lodigiani has been assistant at the Thrombosis Centre of Humanitas research Hospital from 1998 to 2013 and he became Unit Director in 2013.
Humanitas Thrombosis Center is a state-of-the-art service for the proper management of the diagnosis and therapy of venous thromboembolic pathology (deep and superficial venous thrombosis, pulmonary thromboembolism, visceral venous thrombosis) and arterial (myocardial infarction, cerebral stroke, peripheral arterial disease).
Other also rare diseases treated are atypical thrombosis, such as the vascular circulation of the retina, the hearing system and the placental circulation during pregnancy.
Dr. Lodigiani adopts the multidisciplinary approach and works in collaboration with all medical and surgical specialties. In particular, he carries out clinical and instrumental diagnostics (vascular ecocolordoppler) and research on the causes, diagnosis and therapy of thrombotic and bleeding disorders, congenital and acquired. His clinical activity also involves the diagnosis and management of patients suffering from bleeding diseases, such as haemophilia, von Willebrand’s disease and platelet diseases.
In recent years, he has devoted himself with particular interest to the testing, in the role of Principal Investigator in International Clinical Studies, of new antithrombotic drugs and, above all, anticoagulants, which are about to be marketed and will constitute a valid and safe alternative to traditional oral anticoagulant therapy (DOACs). He is also working, with great interest, on researching the causes of idiopathic infertility and the usefulness and effectiveness of some therapeutic strategies, such as the use of anticoagulant drugs, improving the results of artificial insemination procedures. He is the author of numerous articles in international scientific journals and speaker at numerous national and international conferences.
Cita con el médico | precio a consultar |
Terapia con células madre | $6000 |
Cirugía de estimulación cerebral profunda (DBS) | $38000 |
Cita con el médico | precio a consultar |
Tratamiento con medicamentos para la enfermedad de Parkinson | $200 - $250 |
Estetik Cerrahi: Deneyimli cerrahlarımızla, güncel teknikleri kullanarak estetik cerrahi hizmetleri sunuyoruz. Her bireyin ihtiyacına özel çözümler üreterek, doğal ve estetik sonuçlar elde etmeyi amaçlıyoruz.
Saç, Sakal ve Kaş Ekimi: Saç dökülmesi, seyrek sakal ya da kaş problemleriyle mücadele edenlere özel çözümler sunuyoruz. Uzman ekibimiz, kişinin yüz hatlarına uygun doğal sonuçlar elde etmeyi hedefler.
Dolgu Uygulamaları: Yüz gençleştirme ve kontürleme amacıyla kullanılan dolgu uygulamalarını, uzman estetik cerrahlarımız ile güvenli bir şekilde gerçekleştiriyoruz. Doğallığı ön planda tutan yaklaşımımızla, müşterilerimize istedikleri görünüme kavuşmalarında yardımcı oluyoruz.
Mostrar másEstetik Cerrahi: Deneyimli cerrahlarımızla, güncel teknikleri kullanarak estetik cerrahi hizmetleri sunuyoruz. Her bireyin ihtiyacına özel çözümler üreterek, doğal ve estetik sonuçlar elde etmeyi amaçlıyoruz.
Saç, Sakal ve Kaş Ekimi: Saç dökülmesi, seyrek sakal ya da kaş problemleriyle mücadele edenlere özel çözümler sunuyoruz. Uzman ekibimiz, kişinin yüz hatlarına uygun doğal sonuçlar elde etmeyi hedefler.
Dolgu Uygulamaları: Yüz gençleştirme ve kontürleme amacıyla kullanılan dolgu uygulamalarını, uzman estetik cerrahlarımız ile güvenli bir şekilde gerçekleştiriyoruz. Doğallığı ön planda tutan yaklaşımımızla, müşterilerimize istedikleri görünüme kavuşmalarında yardımcı oluyoruz.
El Prof. Jaroslav Michalek es un especialista experimentado en oncología, pediatría, alergología e inmunología clínica con una patente europea para el aislamiento de células madre. Tiene 16 años de experiencia en medicina regenerativa, es presidente del Consorcio Internacional de Terapia Celular e Inmunoterapia, es autor de más de 200 publicaciones, fue profesor en la Universidad Masaryk de 2007 a 2015, obtuvo una beca posdoctoral en la Universidad de Texas Southwestern Facultad de Medicina, y es miembro de múltiples asociaciones profesionales.
Mostrar másEl Prof. Jaroslav Michalek es un especialista experimentado en oncología, pediatría, alergología e inmunología clínica con una patente europea para el aislamiento de células madre. Tiene 16 años de experiencia en medicina regenerativa, es presidente del Consorcio Internacional de Terapia Celular e Inmunoterapia, es autor de más de 200 publicaciones, fue profesor en la Universidad Masaryk de 2007 a 2015, obtuvo una beca posdoctoral en la Universidad de Texas Southwestern Facultad de Medicina, y es miembro de múltiples asociaciones profesionales.